BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 12186559)

  • 1. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.
    Tachi T; Epand RF; Epand RM; Matsuzaki K
    Biochemistry; 2002 Aug; 41(34):10723-31. PubMed ID: 12186559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of positional hydrophobicity in the leishmanicidal activity of magainin 2.
    Guerrero E; Saugar JM; Matsuzaki K; Rivas L
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2980-6. PubMed ID: 15273109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor.
    Kobayashi S; Takeshima K; Park CB; Kim SC; Matsuzaki K
    Biochemistry; 2000 Jul; 39(29):8648-54. PubMed ID: 10913273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action.
    Unger T; Oren Z; Shai Y
    Biochemistry; 2001 May; 40(21):6388-97. PubMed ID: 11371201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity.
    Avrahami D; Shai Y
    Biochemistry; 2002 Feb; 41(7):2254-63. PubMed ID: 11841217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
    Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
    Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.
    Strandberg E; Zerweck J; Horn D; Pritz G; Berditsch M; Bürck J; Wadhwani P; Ulrich AS
    J Pept Sci; 2015 May; 21(5):436-45. PubMed ID: 25898805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of a magainin-PGLa hybrid peptide with membranes: insight into the mechanism of synergism.
    Nishida M; Imura Y; Yamamoto M; Kobayashi S; Yano Y; Matsuzaki K
    Biochemistry; 2007 Dec; 46(49):14284-90. PubMed ID: 18004888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane translocation mechanism of the antimicrobial peptide buforin 2.
    Kobayashi S; Chikushi A; Tougu S; Imura Y; Nishida M; Yano Y; Matsuzaki K
    Biochemistry; 2004 Dec; 43(49):15610-6. PubMed ID: 15581374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magainins as paradigm for the mode of action of pore forming polypeptides.
    Matsuzaki K
    Biochim Biophys Acta; 1998 Nov; 1376(3):391-400. PubMed ID: 9804997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action mechanism of PEGylated magainin 2 analogue peptide.
    Imura Y; Nishida M; Matsuzaki K
    Biochim Biophys Acta; 2007 Oct; 1768(10):2578-85. PubMed ID: 17662233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.
    Lequin O; Ladram A; Chabbert L; Bruston F; Convert O; Vanhoye D; Chassaing G; Nicolas P; Amiche M
    Biochemistry; 2006 Jan; 45(2):468-80. PubMed ID: 16401077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa.
    Matsuzaki K; Mitani Y; Akada KY; Murase O; Yoneyama S; Zasloff M; Miyajima K
    Biochemistry; 1998 Oct; 37(43):15144-53. PubMed ID: 9790678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity.
    Shin A; Lee E; Jeon D; Park YG; Bang JK; Park YS; Shin SY; Kim Y
    Biochemistry; 2015 Jun; 54(25):3921-31. PubMed ID: 26053120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced membrane permeabilization and antibacterial activity of a disulfide-dimerized magainin analogue.
    Dempsey CE; Ueno S; Avison MB
    Biochemistry; 2003 Jan; 42(2):402-9. PubMed ID: 12525167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
    Glukhov E; Burrows LL; Deber CM
    Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orientational and aggregational states of magainin 2 in phospholipid bilayers.
    Matsuzaki K; Murase O; Tokuda H; Funakoshi S; Fujii N; Miyajima K
    Biochemistry; 1994 Mar; 33(11):3342-9. PubMed ID: 8136371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of membrane curvature to the formation of pores by magainin 2.
    Matsuzaki K; Sugishita K; Ishibe N; Ueha M; Nakata S; Miyajima K; Epand RM
    Biochemistry; 1998 Aug; 37(34):11856-63. PubMed ID: 9718308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria.
    Matsuzaki K; Sugishita K; Harada M; Fujii N; Miyajima K
    Biochim Biophys Acta; 1997 Jul; 1327(1):119-30. PubMed ID: 9247173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity.
    Cuervo JH; Rodriguez B; Houghten RA
    Pept Res; 1988; 1(2):81-6. PubMed ID: 2980783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.